Andreas Diendorfer
Overview
Explore the profile of Andreas Diendorfer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daamouch S, Diendorfer A, Hackl M, Christoffel G, Hofbauer L, Rauner M
Front Endocrinol (Lausanne)
. 2025 Jan;
15():1477257.
PMID: 39777220
Type 1 diabetes (T1D) represents a significant health burden worldwide, with associated complications including bone fragility. Current clinical methods and biomarkers for assessing bone health and predicting fracture risk in...
2.
Mazidi Z, Wieser M, Spinu N, Weidinger A, Kozlov A, Vukovic K, et al.
Toxicol In Vitro
. 2024 Nov;
103:105954.
PMID: 39550010
Cyclosporin A (CSA) is a potent immunosuppressive agent in pharmacologic studies. However, there is evidence for side effects, specifically regarding vascular dysfunction. Its mode of action inducing endothelial cell toxicity...
3.
Pultar M, Oesterreicher J, Hartmann J, Weigl M, Diendorfer A, Schimek K, et al.
J Extracell Biol
. 2024 Jun;
3(1):e134.
PMID: 38938681
Extracellular vesicles (EVs) are crucial mediators of cell-to-cell communication in physiological and pathological conditions. Specifically, EVs released from the vasculature into blood were found to be quantitatively and qualitatively different...
4.
Weigl M, Krammer T, Pultar M, Wieser M, Chaib S, Suda M, et al.
bioRxiv
. 2024 Apr;
PMID: 38645053
In the last decade cellular senescence, a hallmark of aging, has come into focus for pharmacologically targeting aging processes. Senolytics are one of these interventive strategies that have advanced into...
5.
Erhart F, Widhalm G, Kiesel B, Hackl M, Diendorfer A, Preusser M, et al.
J Cell Mol Med
. 2024 Apr;
28(8):e18149.
PMID: 38613361
Patients with high-grade gliomas are at high risk of venous thromboembolism (VTE). MicroRNAs (miRNAs) are small non-coding RNAs with multiple roles in tumour biology, haemostasis and platelet function. Their association...
6.
Fleischhacker V, Milosic F, Bricelj M, Kuhrer K, Wahl-Figlash K, Heimel P, et al.
Aging Cell
. 2024 Apr;
23(6):e14139.
PMID: 38578073
Age-induced decline in osteogenic potential of bone marrow mesenchymal stem cells (BMSCs) potentiates osteoporosis and increases the risk for bone fractures. Despite epidemiology studies reporting concurrent development of vascular and...
7.
Anderson J, Jacobsen S, Walters M, Bundgaard L, Diendorfer A, Hackl M, et al.
Front Vet Sci
. 2022 Aug;
9:901269.
PMID: 36003409
Extracellular vesicles comprise an as yet inadequately investigated intercellular communication pathway in the field of early osteoarthritis. We hypothesised that the small non-coding RNA expression pattern in synovial fluid and...
8.
Muralidharan-Chari V, Wurz Z, Doyle F, Henry M, Diendorfer A, Tenenbaum S, et al.
J Biotechnol
. 2020 Oct;
325:360-371.
PMID: 33115662
Currently, stable Chinese hamster ovary cell lines producing therapeutic, recombinant proteins are established either by antibiotic and/or metabolic selection. Here, we report a novel technology, PTSelect™ that utilizes an siRNA...
9.
Coats M, Bydlinski N, Maresch D, Diendorfer A, Klanert G, Borth N
Biotechnol J
. 2019 Sep;
15(2):e1900198.
PMID: 31475780
Obtaining highly productive Chinese hamster ovary (CHO)-cell clones for the production of therapeutic proteins relies on multiple time-consuming selection steps. Several CHO-cell strains with high degrees of genomic and epigenetic...
10.
Klanert G, Jadhav V, Shanmukam V, Diendorfer A, Karbiener M, Scheideler M, et al.
J Biotechnol
. 2016 Mar;
235:150-61.
PMID: 26993211
As Chinese Hamster Ovary (CHO) cells are the cell line of choice for the production of human-like recombinant proteins, there is interest in genetic optimization of host cell lines to...